Diagnostic Excellence Across the Cancer Care Continuum for Primary Care Providers: Screening, Early Detection, Complications, and Survivorship

Nearly 40% of men and women will be diagnosed with cancer in their lifetime. Unfortunately, the vast majority of these cases (>80%) are discovered only after a patient becomes symptomatic or during routine care for an unrelated issue. Less than 20% of cancers are detected through recommended preventive screening tests—a statistic that underscores a massive gap in effective screening, even for malignancies with established guidelines like lung and colorectal cancers. For cancers that lack standard screening protocols, general practice providers serve as the critical first line of defense. Because the signs and symptoms of early-stage cancer can mimic common, everyday conditions, maintaining a high index of suspicion is vital to avoid diagnostic delays that drastically decrease patient survival rates.^[1-3]

This intensive, two-day course is specifically designed to equip primary care clinicians, advanced practice providers, and nurse navigators with the advanced clinical insights needed to optimize early cancer detection. Through an evidence-based approach, attendees will master precision testing paradigms, learn to navigate complex imaging and laboratory choices and proper diagnostic triage.

The curriculum will also address the crucial transition of cancer survivors back to primary care, focusing heavily on cardio-prevention and identifying delayed, high-morbidity complications of modern treatments including immunotherapy related adverse events which may present years later. Lastly, advanced imaging in non-cancer patients often discloses findings that are potentially cancerous but require additional testing for a definitive diagnosis. The majority prove benign, and as such, adherence to evidence-based surveillance guidelines is essential for cost-effective management.

This activity is designed for general practice physicians, family medicine physicians, internal medicine physicians, advanced practice providers (nurse practitioners and physician assistants), nurse navigators (registered nurses), and other primary care clinicians dedicated to improving early cancer detection, high-value diagnostic accuracy, and comprehensive survivorship care. We are pleased to offer flexible learning options, with the opportunity to participate live in person or virtually, or register for on demand access to the recorded program.

References

¹ New Research Highlights Just One In Seven Diagnosed Cancers Found By A Recommended Screening Test
² National Cancer Institute Cancer Statistics
³ Delayed Diagnosis of Cancer

1. Adhere to evidence-based cancer screening and surveillance algorithms across a range of common malignancies.
2. Recognize clinical signs and symptoms reflective of undiagnosed cancers and cancer-related treatment complications and follow precision lab and imaging paradigms.
3. Implement guideline-directed diagnostic algorithms for potentially malignant incidental imaging findings (e.g., lung nodules, pancreatic cysts, and thyroid nodules).

We are pleased to offer flexible learning options, with the opportunity to participate live, either in person or virtually, or view the recorded program on demand following the course. Those planning to attend in person are encouraged to visit our Visiting Us page for information about accommodations, parking, directions, and other details to help plan their visit.

• Register for Live Participation 

• Register for On Demand Access

Registration Fees

• Physicians (MDs, PhDs, DOs): $395

• Advanced Practice Providers: $195

• Nurses and Other Healthcare Professionals: $95

• Residents and Fellows: $50

• Industry Professionals: $695*

• MSK Employees: Complimentary**

Discounted registration is available for select groups, including students, MSK alumni/affiliates, and participants from low- and lower-middle-income countries. View our Policy on Registration Discounts for more information.

For cancellation details, please review our Cancellation Policy.

*An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Review our Registration Policy for Industry Professionals for more information.
**MSK employees receive complimentary registration for all CME programs by signing in with MSK credentials (SSO).

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity has been approved for:

• AMA PRA Category 1 Credit(s)™

• American Board of Internal Medicine (ABIM) MOC

Nursing contact hours are pending.*

*Please note that ANCC Nursing contact hours are available only to participants of the live course. Nursing credit is not available for the on demand version.

MSK Course Director 

Pamela Johnson, MD
Attending, Body Imaging Service 
Department of Radiology

Lonny B. Yarmus, DO, MBA
Attending, Pulmonary Service 
Head of the Division of Subspecialty Medicine
Department of Medicine 

A complete faculty list and schedule will be announced soon.

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.